HDFC Mutual Fund recently trimmed its holding in TV Today Network, and the stock saw a modest rise, while Mangalam Drugs' shares kept climbing despite several investors selling.
HDFC Mutual Fund reduces TV Today stake
On January 7, the fund sold 14.5 lakh shares of TV Today Network, equal to about 2.4% of the company's equity, at ₹138 per share. The transaction brought in roughly ₹20 crore.
At the same time, another investor, Wealth Guardian, bought 3.6 lakh shares (about 0.6%) at ₹137.99, spending nearly ₹5 crore.
- TV Today’s share price moved up 2.4% to around ₹142 after the trades.
- The stock has been trading within a narrow range for the past two weeks.
- HDFC Small Cap Fund previously held around 3% of TV Today as of December 2025.
Multiple sellers in Mangalam Drugs, yet shares surge
Vijay Kedia’s Kedia Securities sold 1.37 lakh shares of Mangalam Drugs and Organics at ₹35.09 each, totaling about ₹48 lakh.
Other sellers included:
- Neo Apex Venture – 80,000 shares at ₹34.44 (≈ ₹27.5 lakh)
- Epitome Trading and Investments – 1.2 lakh shares at ₹34.90 (≈ ₹41.9 lakh)
- Multiplier Share & Stock Advisors – 1.25 lakh shares at ₹34.90 (≈ ₹43.6 lakh)
Despite this selling pressure, Mangalam Drugs’ shares kept climbing, hitting the 5% daily upper‑circuit limit since Dec 29 and gaining more than 47% over eight straight sessions.
What this means for investors
The TV Today sale shows HDFC’s willingness to adjust its media exposure, while the modest price rise suggests the market absorbed the move without major panic.
In contrast, Mangalam Drugs’ continued rally indicates strong buying interest that outweighs the recent sell‑offs, which could signal bullish sentiment for the stock.
Remember, this is just an overview, not a prediction. Always do your own research before making any investment decisions.